SCHEMBL301367

SCHEMBL301367

Nc1ccc(C(=O)Nc2ccc(N)cc2N)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.77
MAPK1 P28482 2/20 0.77
GAA P10253 1/20 0.77
HDAC1 Q13547 9/20 0.70
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
LMNA P02545 1/20 0.58
POLB P06746 1/20 0.58
PKM P14618 1/20 0.58
APEX1 P27695 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
HDAC3 O15379 6/20 0.57
HDAC2 Q92769 5/20 0.57
NCOR2 Q9Y618 3/20 0.57
CYP1A2 P05177 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11591501 0.89 HDAC1 (0.71) MAPTMAPK1GAAHDAC1MEN1
SCHEMBL26775744 0.88 HDAC1 (0.90) MAPTMAPK1GAAHDAC1HDAC3
SCHEMBL9173739 0.87 MAPT (0.65) MAPTMAPK1GAAHDAC1MEN1
SCHEMBL7297525 0.87 MAPT (0.69) MAPTMAPK1GAAHDAC1HDAC3
SCHEMBL10893718 0.86 HDAC1 (0.72) MAPTMAPK1GAAHDAC1MEN1
SCHEMBL9767165 0.84 SMN1; SMN2 (0.74) MAPTMAPK1GAAHDAC1MEN1
SCHEMBL29996129 0.84 HDAC1 (0.63) MAPTMAPK1GAAHDAC1MEN1
SCHEMBL26416452 0.84 HDAC1 (0.63) MAPTMAPK1GAAHDAC1MEN1
SCHEMBL4905569 0.84 MAPT (0.76) MAPTMAPK1GAAHDAC1MEN1
SCHEMBL15551664 0.82 HDAC1 (1.00) GAAHDAC1MEN1KMT2AHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260074224-A1 SUPRAMOLECULE AND RECHARGEABLE LITHIUM BATTERIES INCLUDING THE SAME SAMSUNG SDI CO LTD (KR) 2026-03-12 US disclosed
US-10686187-B2 Slurry for electrode material, method for producing slurry for electrode material, negative electrode, battery, and polyimide-coated active material particles I.S.T CORPORATION (JP) 2020-06-16 US disclosed
EP-3264504-B1 SLURRY FOR ELECTRODE MATERIAL AND METHOD FOR PRODUCING THE SAME, NEGATIVE ELECTRODE, BATTERY, AND POLYIMIDE-COATED ACTIVE MATERIAL PARTICLES IST CORP (JP) 2020-04-08 EP disclosed
US-20180254476-A1 POLYIMIDE-COATED ACTIVE MATERIAL PARTICLES, SLURRY FOR ELECTRODE MATERIAL, NEGATIVE ELECTRODE, BATTERY, AND METHOD FOR PRODUCING POLYIMIDE-COATED ACTIVE MATERIAL PARTICLES I.S.T CORPORATION (JP) 2018-09-06 US disclosed
EP-3264504-A1 POLYIMIDE-COATED ACTIVE MATERIAL PARTICLES, SLURRY FOR ELECTRODE MATERIAL, NEGATIVE ELECTRODE, BATTERY, AND METHOD FOR PRODUCING POLYIMIDE-COATED ACTIVE MATERIAL PARTICLES I.S.T. Corporation (JP) 2018-01-03 EP disclosed
EP-2405513-A1 BINDER COMPOSITION FOR ELECTRODES AND ELECTRODE MIX SLURRY I.S.T. Corporation (JP) 2012-01-11 EP disclosed
US-20110309293-A1 BINDER COMPOSITION FOR ELECTRODES AND ELECTRODE MIX SLURRY I.S.T. CORPORATION (JP) 2011-12-22 US disclosed
US-4192947-A REACTING DIAMINO NITROBENZENE WITH NITROBENZOYL CHLORIDE, CYCLIZING ANILIDE IN AQUEOUS ALKALI, REDUCING NITRO GROUPS WITH SULFIDE CASSELLA AKTIENGESELLSCHAFT (DE) 1980-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260074224-A1 SUPRAMOLECULE AND RECHARGEABLE LITHIUM BATTERIES INCLUDING THE SAME NLRP1, ILK, S100A9 MAPT 2492/4885MAPK1 1794/4885GAA 4345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.